Ads
related to: ocrevus- Safety & Side Effects
View Important Safety & Side Effect
Information On The Official Site
- OCREVUS Medication Guide
Download The Medication Guide
To Learn More About OCREVUS
- Infusion Experience
Learn More About The Infusion
Experience With OCREVUS
- Patient Support
Access Patient Resources
& Information For OCREVUS
- Infusion Checklist
Download A Checklist To Help
Prepare You For Your Infusion
- Patients Taking OCREVUS
Explore The Stories & Experiences
Of People Taking OCREVUS
- Safety & Side Effects
Search results
Halozyme (HALO) Rises 5% as Ocrevus SC Meets Goals in MS Study
Zacks via Yahoo Finance· 11 months agoHalozyme (HALO) rises 5% after Roche's late-stage multiple sclerosis study of subcutaneous...
Roche's Approved Multiple Sclerosis Drug: Subcutaneous Injection At Par With Intravenous Infusion
Benzinga via Yahoo Finance· 11 months agoRoche Holdings AG's (OTC: RHHBY) Phase 3 OCARINA II trial evaluating Ocrevus (ocrelizumab) as a...
How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg
Investor's Business Daily· 11 months agoRoche unveiled positive results Thursday for a rival to TG Therapeutics' one-hour infusion for...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 10 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
Roche (RHHBY) Q3 Revenues Dip on Lower COVID-19-Related Sales
Zacks via Yahoo Finance· 2 years agoSwiss pharma giant Roche Holding AG’s RHHBY third-quarter revenues declined 6% to CHF 14.7 billion...
Roche sales decline more than expected as COVID products slide
Reuters via Yahoo Finance· 2 years ago(Reuters) -Roche's quarterly sales declined 6% as a slump in COVID-19 treatments and diagnostic...
The Zacks Analyst Blog Highlights Roche, Wells Fargo, General Aerospace and Key Tronic
Zacks via Yahoo Finance· 16 hours agoFor Immediate Release Chicago, IL – June 5, 2024 – Zacks.com announces the list of stocks featured...
What Is the First Line of Treatment for Multiple Sclerosis?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Lindsay Cook, PharmD In multiple sclerosis (MS), the immune system attacks the...
Top-Notch Biotech TG Therapeutics Breaks Out On 'Solid Jump' In Sales
Investor's Business Daily· 1 year agoTG Therapeutics' new multiple sclerosis drug, Briumvi, experienced a "solid jump" in March sales,...
Biogen (BIIB) Beats on Q2 Earnings & Sales, Ups 2022 Guidance
Zacks via Yahoo Finance· 2 years agoBiogen BIIB reported second-quarter 2022 earnings per share (EPS) of $5.25, which significantly beat...
Ads
related to: ocrevus